Place
To
Work® Certified SEP 2026-SEP 2027 INDIA
Since 1983
A Legacy of Quality and Growth
Since 1983
Kwality Pharmaceuticals Ltd. : A Legacy of Quality and Growth
For over 40 years, Kwality Pharmaceuticals Ltd. has been a trusted name in the healthcare sector, synonymous with unparalleled growth and absolute reliability. We are driven by a customer-centric vision, committed to delivering high-quality products and services that maximize value for our valued customers.
Our journey began in 1983 with a modest venture into finished pharmaceuticals. Under the leadership of our Chairman Mr. Ramesh Arora, we secured our first drug license. Kwality Pharmaceuticals Ltd. has established itself as a leading manufacturer and exporter of pharmaceutical formulations.
-
1983Established
-
40+ Yearsof Experience
-
GlobalMarket Presence
-
Quality-LedManufacturing
A Decade of Growth
Our Company has experienced a remarkable trajectory of growth and expansion over the past six years. This growth has been fueled by a strategic focus on innovation, regulatory compliance, and global market penetration.
Key Milestones and Achievements
Innovation | Expansion | Impact-
2016
A New ChapterSuccessful listing on the BSE SME exchange marked a significant milestone in our journey.
-
2017-2021
Building Capabilities A period of rapid expansion, characterized by:- Upgrades to manufacturing facilities, including the Generic Block and Oncology Unit.
- Gaining of regulatory approvals from key global markets (Rest of the World).
- Commissioning of new production lines for Cephalosporins and Beta lactams.
- Development of innovative platform technologies and complex injectable products.
-
2022-2025
Expanding Globally A focus on global reach and product diversification:- Received approval of EU GMP and PIC/S GMP certifications with many others.
- Establishment of a Biological Unit and development of innovative products.
- Expansion into new markets, including the EU, South Africa, Brazil, and Russia/CIS.
-
2026-2027
The Next Phase DSIR Recognition for Kwality Pharmaceuticals Ltd. "Innovation Centre".- Construction of Hormonal Facilities (commencement by QI 2027).
- 100 plus product approvals across market with approvals in SRA market.
- EU-GMP approvals for oral solids, general injectables and beta-lactam units.
Product Filing & Approval
Our product filing & market approvals have mirrored our operational growth, with a steady increase over the past few years.
Possibilities
Together
Product approvals across market
Quality you can trustMilestones
Got registered with
the Bombay Stock Exchange in 2016
Continuous upgradation of our state of the art manufacturing units by installing the latest equipment for the production of best quality products.
Started production of Cytotoxic drugs, following EU standards at our new unit at Jassur, Himachal Pradesh.
Attained PIC/S GMP accreditation for FDA, Iran
Developed our own integrated software – “Friends” – for prompt updates for customer service and information
World-class QA, QC, Micro Lab, R&D to ensure best in class quality
11 Molecules registered in emerging markets
WHO approved for cephalosporin unit
Enhanced injectables capabilities at Amritsar facility
Developed over 10 comples products including microspheres, Liposomes, Ophthalmic susp, etc
